NCT04383743 2025-09-18
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer
University of Washington
Phase 2 Completed
Clinical Trials
10 trialsNCT07043790 2025-07-30
Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma
Ain Shams University
Phase NA Completed
NCT06928220 2025-04-15
CIMMIS
Fundacio Puigvert
Phase NA Completed
NCT03674424 2025-02-26
AURA
Jules Bordet Institute
Phase 2 Completed
NCT02924480 2022-03-09
Lidocaine
CAMC Health System
Phase NA Completed
NCT04570176 2022-02-16
Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System
The Affiliated Hospital of Qingdao University
Phase NA Completed
NCT03977831 2021-01-26
Study Comparing Open Radical Cystectomy With Robot-assisted Cystectomy in Patients With Bladder Cancer
Rigshospitalet, Denmark
Phase NA Completed
NCT02861196 2020-12-17
Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Completed
NCT00380029 2017-07-19
Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT00585689 2015-11-30
Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed